291 related articles for article (PubMed ID: 38279232)
1. Insights into How Plant-Derived Extracts and Compounds Can Help in the Prevention and Treatment of Keloid Disease: Established and Emerging Therapeutic Targets.
Boo YC
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279232
[TBL] [Abstract][Full Text] [Related]
2. Extract of Aneilema keisak inhibits transforming growth factor-β-dependent signalling by inducing Smad2 downregulation in keloid fibroblasts.
Kim WS; Lee JS; Bae GY; Kim JJ; Chin YW; Bahk YY; Min HG; Cha HJ
Exp Dermatol; 2013 Jan; 22(1):69-71. PubMed ID: 23278899
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.
Luo L; Li J; Liu H; Jian X; Zou Q; Zhao Q; Le Q; Chen H; Gao X; He C
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498357
[TBL] [Abstract][Full Text] [Related]
4. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL
J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway.
Nagar H; Kim S; Lee I; Kim S; Choi SJ; Piao S; Jeon BH; Oh SH; Kim CS
Sci Rep; 2021 Jan; 11(1):500. PubMed ID: 33436666
[TBL] [Abstract][Full Text] [Related]
7. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
8. Molecular signalings in keloid disease and current therapeutic approaches from natural based compounds.
Unahabhokha T; Sucontphunt A; Nimmannit U; Chanvorachote P; Yongsanguanchai N; Pongrakhananon V
Pharm Biol; 2015 Mar; 53(3):457-63. PubMed ID: 25331681
[TBL] [Abstract][Full Text] [Related]
9. Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location.
Zhao MJ; Chen SY; Qu XY; Abdul-Fattah B; Lai T; Xie M; Wu SD; Zhou YW; Huang CZ
Curr Med Sci; 2018 Oct; 38(5):894-902. PubMed ID: 30341526
[TBL] [Abstract][Full Text] [Related]
10. Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.
Marty P; Chatelain B; Lihoreau T; Tissot M; Dirand Z; Humbert P; Senez C; Secomandi E; Isidoro C; Rolin G
Biomed Pharmacother; 2021 Mar; 135():111182. PubMed ID: 33433355
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression.
Li J; Li Z; Wang S; Bi J; Huo R
Bioengineered; 2022 Apr; 13(4):8515-8525. PubMed ID: 35333672
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
Zhang Y; Cheng C; Wang S; Xu M; Zhang D; Zeng W
Life Sci; 2019 Sep; 232():116637. PubMed ID: 31288014
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
14. Nonmuscle Myosin II Activation Regulates Cell Proliferation, Cell Contraction, and Myofibroblast Differentiation in Keloid-Derived Fibroblasts.
Lu YY; Fang CC; Hong CH; Wu CH; Lin YH; Chang KL; Lee CH
Adv Wound Care (New Rochelle); 2020 Sep; 9(9):491-501. PubMed ID: 32941122
[No Abstract] [Full Text] [Related]
15. Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts.
Li T; Zhao J
Mol Med Rep; 2018 Mar; 17(3):4057-4061. PubMed ID: 29286129
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A for the treatment of keloids.
Gauglitz GG; Bureik D; Dombrowski Y; Pavicic T; Ruzicka T; Schauber J
Skin Pharmacol Physiol; 2012; 25(6):313-8. PubMed ID: 22948093
[TBL] [Abstract][Full Text] [Related]
17. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
Chua AW; Gan SU; Ting Y; Fu Z; Lim CK; Song C; Sabapathy K; Phan TT
J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways.
Tang M; Bian W; Cheng L; Zhang L; Jin R; Wang W; Zhang Y
Int J Mol Med; 2018 Mar; 41(3):1487-1499. PubMed ID: 29328420
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of fibronectin extra domain B suppresses TGF-β1-mediated cell proliferation and collagen deposition in keloid fibroblasts via AKT/ERK signaling pathway.
Cui J; Li Z; Jin C; Jin Z
Biochem Biophys Res Commun; 2020 Jun; 526(4):1131-1137. PubMed ID: 32317186
[TBL] [Abstract][Full Text] [Related]
20. Calcimycin Suppresses S100A4 Expression and Inhibits the Stimulatory Effect of Transforming Growth Factor β1 on Keloid Fibroblasts.
Zhao YX; Ho CK; Xie Y; Chen YH; Li HZ; Zhang GY; Li QF
Ann Plast Surg; 2018 Aug; 81(2):163-169. PubMed ID: 29846215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
